☆ 4.7 Meeting Abstract

Participant hopes and expectations regarding outcomes of genomic sequencing research in pediatric oncology.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Journal

JOURNAL OF CLINICAL ONCOLOGY

Volume 37, Issue 15, Pages -

Publisher

AMER SOC CLINICAL ONCOLOGY

DOI: 10.1200/JCO.2019.37.15_suppl.10020

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Genetics & Heredity

Perspectives and preferences regarding genomic secondary findings in underrepresented prenatal and pediatric populations: A mixed-methods approach

Shannon Rego, Hannah Hoban, Simon Outram, Astrid N. Zamora, Flavia Chen, Nuriye Sahin-Hodoglugil, Beatriz Anguiano, Matthew Norstad, Tiffany Yip, Billie Lianoglou, Teresa N. Sparks, Mary E. Norton, Barbara A. Koenig, Anne M. Slavotinek, Sara L. Ackerman

Summary: This study examined the preferences and reasons for accepting or declining secondary findings among underrepresented minority pediatric or prenatal populations. The results showed that 37% of families did not want at least one category of secondary findings, indicating hesitancy towards receiving all available results. The findings highlight the importance of including diverse populations in genomic research.

GENETICS IN MEDICINE (2022)

Add to Collection

Article Oncology

Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma

Megan H. H. Jagosky, Colin J. J. Anderson, James T. T. Symanowski, Nury M. M. Steuerwald, Carol J. J. Farhangfar, Emily A. A. Baldrige, Jennifer H. H. Benbow, Michael B. B. Livingston, Joshua C. C. Patt, Will A. A. Ahrens, Jeffrey S. S. Kneisl, Edward S. S. Kim

Summary: This is one of the largest retrospective reports analyzing genomic aberrations in relation to clinical outcomes for patients with DDLPS. The study suggests that therapies targeting the identified abnormalities should be explored and further confirmation of prognostic markers is needed. Dedifferentiated liposarcoma is one of the most common subtypes of soft tissue sarcoma, but little is known about its molecular aberrations and their impact on outcomes.

CANCER MEDICINE (2023)

Add to Collection

Article Health Care Sciences & Services

Pediatric Oncologists' Experiences Returning and Incorporating Genomic Sequencing Results into Cancer Care

Rebecca L. Hsu, Amanda M. Gutierrez, Sophie K. Schellhammer, Jill O. Robinson, Sarah Scollon, Richard L. Street, Alyssa N. Salisbury, Stacey Pereira, Sharon E. Plon, Janet Malek, D. Williams Parsons, Amy L. McGuire

Summary: Pediatric oncologists find collaboration with genetic counselors crucial in interpreting and communicating genomic results, with most adopting a collaborative approach in discussing findings. Genetic counselors play key roles in answering families' questions and simplifying information during the return of results process. Challenges include conveying uncertain information in simple terms and addressing families' emotional responses, emphasizing the essential support provided by genetic counselors and geneticists in the return of genomic results process.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Article Health Care Sciences & Services

Outcomes of Returning Medically Actionable Genomic Results in Pediatric Research

Amy A. Blumling, Cynthia A. Prows, Margaret H. Harr, Wendy K. Chung, Ellen Wright Clayton, Ingrid A. Holm, Georgia L. Wiesner, John J. Connolly, John B. Harley, Hakon Hakonarson, Michelle L. McGowan, Erin M. Miller, Melanie F. Myers

Summary: The study aimed to assess the clinical outcomes of returning medically actionable genomic screening results in pediatric populations. The results showed that 77.8% of the participants experienced a change in healthcare following the return of pathogenic variants, with common outcomes including imaging/laboratory testing and health behavior recommendations.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Add to Collection

Article Genetics & Heredity

Parental Hopes and Understandings of the Value of Prenatal Diagnostic Genomic Sequencing: A Qualitative Analysis

Simon M. Outram, Julia E. H. Brown, Astrid N. Zamora, Nuriye Sahin-Hodoglugil, Sara L. Ackerman

Summary: Parents have clear expectations of prenatal genomic sequencing, including identifying the cause of fetal anomalies, guidance for current pregnancy, and support for future family planning. They see genomic sequencing as a means to acquire more knowledge, although they are aware that it may raise further questions. Positive results are seen as valuable, while negative results provide certainty and reassurance. Genetic counselors play a crucial role in guiding families through the uncertainties of genomic sequencing.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Oncology

Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study

Scott S. Short, Zachary J. Kastenberg, Guo Wei, Alex Bondoc, Roshni Dasgupta, Greg M. Tiao, Erin Watters, Todd E. Heaton, Dimitra Lotakis, Michael P. La Quaglia, Andrew J. Murphy, Andrew M. Davidoff, Sara A. Mansfield, Max R. Langham, Timothy B. Lautz, Riccardo A. Superina, Katherine C. Ott, Marcus M. Malek, Katrina M. Morgan, Eugene S. Kim, Abigail Zamora, Danny Lascano, Jonathan Roach, Joseph T. Murphy, David H. Rothstein, Sanjeev A. Vasudevan, Richard Whitlock, Dave R. Lal, Brian Hallis, Andreana Butter, Reto M. Baertschiger, Eveline Lapidus-Krol, Juan Putra, Elisabeth R. Tracy, Jennifer H. Aldrink, Jordan Apfeld, Hau D. Le, Keon Y. Park, Barrie S. Rich, Richard D. Glick, Elizabeth A. Fialkowski, Alan F. Utria, Rebecka L. Meyers, Kimberly J. Riehle

Summary: This study provides the largest detailed dataset on children with hepatocellular carcinoma. It identifies key differences between subtypes of hepatocellular carcinoma, which is crucial for improving understanding and clinical management of these rare cancers.

CANCER (2022)

Add to Collection

Article Oncology

Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator

Albrecht Stenzinger, Brian Cuffel, Noman Paracha, Eric Vail, Jesus Garcia-Foncillas, Clifford Goodman, Ulrik Lassen, Gilles Vassal, Sean D. Sullivan

Summary: This article presents a simple metric, cost per correctly identified patient (CCIP), to inform policies on genomic testing strategies. The results show that, in most evaluated cancer types, the cost to correctly identify patients using NGS is lower than sequential single-gene testing (SGT).

ONCOLOGIST (2023)

Add to Collection

Article Oncology

A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics

Haiyong Wang, Yongfeng Ding, Yanyan Chen, Junjie Jiang, Yiran Chen, Jun Lu, Mei Kong, Fan Mo, Yingying Huang, Wenyi Zhao, Ping Fang, Xiangliu Chen, Xiaodong Teng, Nong Xu, Yimin Lu, Xiongfei Yu, Zhongqi Li, Jing Zhang, Haohao Wang, Xuanwen Bao, Donghui Zhou, Ying Chi, Tianhua Zhou, Zhan Zhou, Shuqing Chen, Lisong Teng

Summary: By integrating multidimensional genomic features, this study proposed a novel genomic classification system for gastric cancer, categorizing it into four subtypes with distinct clinical phenotypes and prognosis. This classification system provides new insights for genome-guided risk stratification and disease management.

GASTRIC CANCER (2021)

Add to Collection

Article Genetics & Heredity

Genomic answers for children: Dynamic analyses of > 1000 pediatric rare disease genomes

Ana S. A. Cohen, Emily G. Farrow, Ahmed T. Abdelmoity, Joseph T. Alaimo, Shivarajan M. Amudhavalli, John T. Anderson, Lalit Bansal, Lauren Bartik, Primo Baybayan, Bradley Belden, Courtney D. Berrios, Rebecca L. Biswell, Pawel Buczkowicz, Orion Buske, Shreyasee Chakraborty, Warren A. Cheung, Keith A. Coffman, Ashley M. Cooper, Laura A. Cross, Tom Curran, Thuy Tien T. Dang, Mary M. Elfrink, Kendra L. Engleman, Erin D. Fecske, Cynthia Fieser, Keely Fitzgerald, Emily A. Fleming, Randi N. Gadea, Jennifer L. Gannon, Rose N. Gelineau-Morel, Margaret Gibson, Jeffrey Goldstein, Elin Grundberg, Kelsee Halpin, Brian S. Harvey, Bryce A. Heese, Wendy Hein, Suzanne M. Herd, Susan S. Hughes, Mohammed Ilyas, Jill Jacobson, Janda L. Jenkins, Shao Jiang, Jeffrey J. Johnston, Kathryn Keeler, Jonas Korlach, Jennifer Kussmann, Christine Lambert, Caitlin Lawson, Jean-Baptiste Le Pichon, James Steven Leeder, Vicki C. Little, Daniel A. Louiselle, Michael Lypka, Brittany D. McDonald, Neil Miller, Ann Modrcin, Annapoorna Nair, Shelby H. Neal, Christopher M. Oermann, Donna M. Pacicca, Kailash Pawar, Nyshele L. Posey, Nigel Price, Laura M. B. Puckett, Julio F. Quezada, Nikita Raje, William J. Rowell, Eric Rush, Venkatesh Sampath, Carol J. Saunders, Caitlin Schwager, Richard M. Schwend, Elizabeth Shaffer, Craig Smail, Sarah Soden, Meghan E. Strenk, Bonnie R. Sullivan, Brooke R. Sweeney, Jade B. Tam-Williams, Adam M. Walter, Holly Welsh, Aaron M. Wenger, Laurel K. Willig, Yun Yan, Scott T. Younger, Dihong Zhou, Tricia N. Zion, Isabelle Thiffault, Tomi Pastinen

Summary: This study provided comprehensive diagnostic and candidate analyses for a pediatric rare disease cohort, achieving diagnostic rates ranging from 11% to 34.5%. HiFi long-read genome sequencing yielded increased discovery rate with more rare coding SVs. Variants and genes of unknown significance remained common in nondiagnostic cases.

GENETICS IN MEDICINE (2022)

Add to Collection

Article Oncology

The Genomic Landscape of Lobular Breast Cancer

Amy E. McCart Reed, Samuel Foong, Jamie R. Kutasovic, Katia Nones, Nicola Waddell, Sunil R. Lakhani, Peter T. Simpson

Summary: This study presents a meta-analysis of invasive lobular carcinoma (ILC) sequencing data to provide a unified resource for ILC research, confirming the prognostic significance of clinico-pathology features and genomics in this unique tumor type. The genomic landscape significantly impacts the variable natural history and overall survival of ILC patients.

CANCERS (2021)

Add to Collection

Review Genetics & Heredity

A Simple Practical Guide to Genomic Diagnostics in a Pediatric Setting

Alan Taylor, Zeinab Alloub, Ahmad Abou Tayoun

Summary: As genetic testing becomes more prevalent in medical specialties, healthcare providers often lack the necessary support to order appropriate tests for their patients. Educating providers on genetic testing concepts and proper utilization is crucial for timely diagnoses and cost-effective testing strategies.

GENES (2021)

Add to Collection

Article Oncology

A Comparison of Patients' and Physicians' Knowledge and Expectations Regarding Precision Oncology Tests

Navdeep Dehar, Tasnima Abedin, Patricia Tang, Gwyn Bebb, Winson Y. Y. Cheung

Summary: The study reveals discrepancies between patients and cancer physicians in their understanding and expectations of genomic testing, highlighting the importance of improving education and communication to align expectations and improve clinical decision making.

CURRENT ONCOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable Alterations

Fabio Pastorino, Mario Capasso, Chiara Brignole, Serena Giglio, Veronica Bensa, Sueva Cantalupo, Vito Alessandro Lasorsa, Annalisa Tondo, Rossella Mura, Angela Rita Sementa, Alberto Garaventa, Mirco Ponzoni, Loredana Amoroso

Summary: Neuroblastoma is the most common extracranial solid tumor in childhood. The prognosis for patients with metastatic relapse or refractory disease is poor. The integration of genome sequencing into standard clinical practice is necessary for personalized therapy. In this study, whole exome sequencing was performed on two patients with relapsed NB, and actionable genetic variations were identified and treated accordingly. The results demonstrate the feasibility of incorporating clinical WES into pediatric oncology practice.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Oncology

Frontiers in Bladder Cancer Genomic Research

Yi Li, Lihui Sun, Xiangyang Guo, Na Mo, Jinku Zhang, Chong Li

Summary: Most etiology studies of bladder cancer focus on genetic changes, surgery is the main treatment but chemotherapy is needed due to high recurrence rates, and there are differences in chemosensitivity among patients.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Genetics & Heredity

Parental Guidance Suggested: Engaging Parents as Partners in Research Studies of Genomic Screening for a Pediatric Population

Sabrina N. Powell, Grace Byfield, Ashley Bennetone, Annabelle M. Frantz, Langston K. Harrison, Erin R. James-Crook, Heather Osborne, Thomas H. Owens, Jonathan L. Shaw, Julianne O'Daniel, Laura V. Milko

Summary: Recent advances in genomic sequencing and genomic medicine are transforming clinical care. Genetic sequencing has the potential to significantly enhance the clinical utility of newborn screening, but there are still significant barriers to overcome. Stakeholder-informed implementation research, with parents as crucial stakeholders, is poised to address these barriers. The Community Research Board (CRB), consisting of diverse parents, is actively collaborating with researchers to gather parental perspectives and develop strategies for the equitable integration of genomic sequencing in newborn screening.

FRONTIERS IN GENETICS (2022)

Add to Collection

Editorial Material Psychology, Developmental

Adolescent Shared Decision-Making: Where We Have Been and Where We are Going

Jonathan M. Marron

JOURNAL OF ADOLESCENT HEALTH (2021)

Add to Collection

Article Oncology

Socioeconomic disparities in survival after high-risk neuroblastoma treatment with modern therapy

Daniel J. Zheng, Anran Li, Clement Ma, Karina B. Ribeiro, Lisa Diller, Kira Bona, Jonathan M. Marron

Summary: This study investigated the relationship between socioeconomic status and overall survival in children with high-risk neuroblastoma, finding that survival disparities among different SES groups have not widened over time. Despite improvements in overall survival, children from low socioeconomic backgrounds continue to experience inferior outcomes, highlighting the importance of interventions to address this disparity.

PEDIATRIC BLOOD & CANCER (2021)

Add to Collection

Editorial Material Oncology

Striving for equity: Patient prioritization during a critical cancer drug shortage

Brittany M. Lee, Nancy S. Jecker, Jonathan M. Marron, Abby R. Rosenberg

PEDIATRIC BLOOD & CANCER (2021)

Add to Collection

Article Pediatrics

The Case of Billy Best: 25 Years Later

Jonathan M. Marron, Zamina Mithani, Elaine C. Meyer

Summary: Billy Best was diagnosed with Hodgkin lymphoma at age 16 and gained national attention for opting for complementary and alternative medicine over standard chemotherapy. His case, which is frequently referenced in pediatrics and bioethics, highlights the continued need to optimize communication, improve treatment toxicities, integrate adolescent perspectives into treatment decisions, and navigate the roles of CAM and media in pediatric health care amidst the changing landscape of healthcare.

PEDIATRICS (2021)

Add to Collection

Editorial Material Oncology

Ethics-Centered Guidelines for Social Media Use by Oncology Professionals: A Call to Action

Utkarsh C. Shukla, Rachel B. Jimenez, Reshma Jagsi, Abby R. Rosenberg, Jonathan M. Marron, Laura J. Carfang, Colleen A. Lawton, Don S. Dizon, Matthew S. Katz

JCO ONCOLOGY PRACTICE (2022)

Add to Collection

Editorial Material Oncology

A Process Framework for Ethically Deploying Artificial Intelligence in Oncology

Andrew Hantel, Dillon D. Clancy, Kenneth L. Kehl, Jonathan M. Marron, Eliezer M. Van Allen, Gregory A. Abel

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Editorial Material Oncology

Ethics Consultation in Oncology: The Search for Quality in Quantity

Jonathan M. Marron, Andrew Hantel, Gregory A. Abel, Jeffrey M. Peppercorn

JCO ONCOLOGY PRACTICE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Parents' understanding of genome and exome sequencing for pediatric health conditions: a systematic review

Jessica Gereis, Kate Hetherington, Lauren Ha, Eden G. Robertson, David S. Ziegler, Kristine Barlow-Stewart, Katherine M. Tucker, Jonathan M. Marron, Claire E. Wakefield

Summary: This article summarizes the evidence regarding the actual and perceived understanding of genome and exome sequencing (GS/ES) among parents of children undergoing testing. The study found that parents had varied understanding of different aspects of sequencing, including potential clinical benefits, nature of secondary findings, and data privacy issues. Genetic counseling was shown to improve parents' understanding.

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Add to Collection

Letter Oncology

Words Matter

Daniel J. Benedetti, Jonathan M. Marron, Stefanie M. Thomas, Amy E. Caruso Brown, Kimberly A. Pyke-Grimm, Liza-Marie Johnson, Eric Kodish, Yoram Unguru

JOURNAL OF CLINICAL ONCOLOGY (2023)

Add to Collection

Article Health Care Sciences & Services

What's in a Name? Parents' and Healthcare Professionals' Preferred Terminology for Pathogenic Variants in Childhood Cancer Predisposition Genes

Jacqueline D. Hunter, Eden G. Robertson, Kate Hetherington, David S. Ziegler, Glenn M. Marshall, Judy Kirk, Jonathan M. Marron, Avram E. Denburg, Kristine Barlow-Stewart, Meera Warby, Katherine M. Tucker, Brittany M. Lee, Tracey A. O'Brien, Claire E. Wakefield

Summary: There is a lack of consensus in current literature/guidelines regarding the appropriate term to communicate a cancer-related disease-causing germline variant in childhood cancer. Preferences vary among parents, genetics professionals, and pediatric oncologists. The term 'faulty gene' is perceived as having negative connotations and potentially blaming parents/children. Health professionals face challenges in selecting a term that is scientifically accurate, easily understood, and not distressing to families. It is important to consider families' preferred terminology while providing accurate explanations of genetic findings.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Add to Collection

Editorial Material Ethics

Pediatric Brain Death Testing Over Parental Objections: Not an Ethically Preferable Option

Jonathan M. M. Marron

AMERICAN JOURNAL OF BIOETHICS (2023)

Add to Collection

Editorial Material Ethics

Can the Extraordinary Become Ordinary? Re-Examining the Ethics of ECMO-DT

Eric. J. J. Kim, Jonathan. M. M. Marron

AMERICAN JOURNAL OF BIOETHICS (2023)

Add to Collection

Article Oncology

Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives

Claire E. Wakefield, Kate Hetherington, Eden G. Robertson, Mark W. Donoghoe, Jacqueline D. Hunter, Janine Vetsch, Jonathan M. Marron, Katherine M. Tucker, Glenn M. Marshall, Alexander Broom, Michelle Haber, Vanessa Tyrrell, David Malkin, Loretta Lau, Marion K. Mateos, Tracey A. O'Brien, David S. Ziegler

Summary: Parents and patients rarely regretted participating in a childhood cancer precision medicine trial, even when their hopes were not fulfilled. Most participants found the trial beneficial and expressed high satisfaction.

BRITISH JOURNAL OF CANCER (2023)

Add to Collection

Article Oncology

Parents' and adolescents' perspectives and understanding of information about childhood cancer precision medicine

Jessica M. Gereis, Kate Hetherington, Eden G. Robertson, Rebecca Daly, Mark W. Donoghoe, David S. Ziegler, Glenn M. Marshall, Loretta M. S. Lau, Jonathan M. Marron, Claire E. Wakefield

Summary: This study investigated the understanding of parents and adolescent patients participating in a precision medicine clinical trial for childhood cancer. The majority of parents were satisfied with the information materials but had low actual understanding of precision medicine. The study suggests the need for improving the language and format of the materials and providing targeted information resources to enhance understanding of precision medicine.

CANCER (2023)

Add to Collection

Review Public, Environmental & Occupational Health

Identifying and Addressing Health Disparities among African American Men with Prostate Cancer: a Systematic Literature Review

Emily Quach

Summary: The research focuses on the determinants leading to health disparities among African American Men with Prostate Cancer, highlighting the need for oncologists to take a more central role in preventing premature death and implementing evidence-based interventions. Shared decision-making in screening and diagnosis is crucial in closing health disparities and improving overall health outcomes.

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.